Advancing LABORATORY AND CLINICAL SUCCESS
Accurate, scalable organoids for drug discovery and personalized medicine
Drug development is failing patients and costing billions.
90% of drugs fail in clinical trials and patients don’t get personalized therapy that would most benefit them.
ProxyBio transforms how drugs are developed
and how patients receive treatment.
Our Solution
Patient-derived organoid models to accurately predict human response
Our three-pronged approach utilizes human-derived organoids with unified AI powered analysis to enable rapid and reliable validation. With high-throughput automation results are scalable at single-cell resolution.
Partner with us
ProxyBio’s organoid technology provides the missing link between laboratory discovery and clinical success.
By creating patient-specific models that accurately predict drug efficacy and safety, we’re transforming how drugs are developed and how patients receive treatment.
